showed a trendp = 0.09
In this subgroup analysis of IVIg‐naïve patients, the difference in lesion area showed a trend (5.0 ± 4.0 vs. 1.1 ± 0.27 cm 2 , p = 0.09).
In this subgroup analysis of IVIg‐naïve patients, the difference in lesion area showed a trend (5.0 ± 4.0 vs. 1.1 ± 0.27 cm 2 , p = 0.09).
However, at 1 week, ultrasound showed a trend towards a lower ratio of circuit flow to CCO (0.346 ± 0.09; P = 0.09), higher UA‐PI (0.67 ± 0.18; P = 0.03) and a higher DV‐PI (0.73 ± 0.29; P = 0.07) in the three non‐survivors compared to survivors.
Gender also showed a trend (beta = −0.29, p = 0.09).
Regarding length of ICU stay, pooled analysis of 12 studies showed a trend toward reduction in the melatonin group compared with controls (MD -0.45 days, 95% CI -1.10 to 0.20, P = 0.09, I 2 = 68%, Figure 7B ), although this did not reach statistical significance.
The intervention also showed a trend toward statistical significance in abstinence knowledge scores (0.129, P =.09).
The comparison between foetuses with adequate development and foetuses affected by IUGR showed no significant differences in the IB breed, but IUGR conceptuses from the L group showed a trend for a higher plasma cholesterol concentrations (66.7±11.0 vs. 54.7 2.2, P = 0.09), due to a significant higher level of HDL-c (14.4±2.2 vs. 5.0±0.7, P <0.0005).
IL-6 showed a trend towards an increase in prolactinoma patients (1.1 [IQR 0.6–1.5] pg/ml in cases vs. 0.6 [IQR 0.5–1.0] pg/ml in controls, P = 0.09).
Exercise volume Although the subgroup analysis showed a trend toward statistical significance in FBG (χ 2 = 2.91, p = 0.09) and 2-hPBG (χ 2 = 3.20, p = 0.07) across exercise volumes, the high-volume subgroup (>600 MET-min/week) demonstrated substantially greater effects on FBG (SMD = −2.26, 95 % CI [−3.40, −1.13], I 2 = 97 %, p < 0.0001) and 2-hPBG (SMD = −3.24, 95 % CI [−5.01, −1.48], I 2 = 98 %, p = 0.0003).
A multivariable analysis adjusted for patient’s gender, age, income quartile, primary payor and comorbidities showed a trend towards lower in-hospital mortality and higher ICU utilization in NH-Blacks when compared to NH-Whites (OR 0.76, 95% CI 0.55–1.05, p = 0.09 and OR 1.29, 95% CI 0.96–1.72, p = 0.09, respectively) and lower utilization of palliative care services in NH-Blacks when compared with NH-Whites (OR 0.61, 95% CI 0.42–0.88, p = 0.01) (Table 2 ).
As for the relationship between sleep measures of the night preceding the DRM session and subsequent DRM performance, we observed a positive correlation between the total number of false memories and the number of night awakenings ( r = 0.267, p = 0.05), whereas the total number of veridical memories showed a trend to a significant positive correlation with sleep duration ( r = 0.266, p = 0.09).
However, the triangular index showed a trend toward lower values in patients of Group 3 ( p = 0.09).
Similarly female cKO animals showed a trend of higher latency to reach hidden platform on day 4 and 5 ( p = 0.09).
Incident participants enrolled within 6 months of biopsy showed a trend toward higher urinary sC5b9-to-protein ratio in high-risk participants (0.15 [0.08–0.31] vs. 0.03 [0–0.20] μg/g, p = 0.09).
Persistent blood MMP-9 elevation throughout post-SAH days 0–14 showed a trend towards association with 3-month SAH outcome in a longitudinal regression model ( p = 0.09).
baseline EDSS showed a trend toward significance: r = −0.32, p = 0.09).
For Model 2 a sensitivity analysis of biopsy type (Table 3 ) showed that first TCMR on a for‐cause biopsy was a significant correlate of death‐censored and all‐cause graft loss, while first TCMR on a surveillance biopsy showed a trend ( p = .09) toward an increased risk of death‐censored allograft loss and no significant association with all‐cause allograft loss after adjustment for baseline covariates, DGF, and ABMR.
Primary site on the head and neck showed a trend toward worse MSS when calculated from time of ITM resection ( p = 0.09; Table 3 ).
Investigation of lifetime hours of MT on RT variance revealed that the variance in RTs at T1 also showed a trend toward being lower with greater lifetime hours of MT practice, when adjusted for age (slope for regression of RT variability on meditation experience: –.039, p = .090; see also Fig. 2c ).
Heart rate in ETOH males was significantly increased in comparison with MD males (Part A in S3 Fig , p<0.05) and showed a trend to increase in ETOH vs MD females (p<0.09).
An ANCOVA on Time 4 executive function controlling for Time 1 only showed a trend toward a difference, with Montessori children scoring more highly: F (2,118) = 3.00, p = 0.09, η p 2 = 0.03.
Additionally, translational evidence from fetal plasma showed a trend toward lower PlGF ( P =0.09) but no changes in VEGF circulating levels ( Figure 4D and 4F ).
Patients who received regorafenib in 2nd line versus 3rd or higher line of treatment showed a trend towards improved OS, without statistical significance ( p = 0.0900) (Fig. 2D ).
Comparison between CON and MIA groups using one-way RM-ANOVA failed to reach statistical significance, although BI 409306 treatment showed a trend for attenuation of distance moved following Amph treatment (main effect of groups; F [4,40] = 2.1; P = 0.09; Fig. 1C ).
However, total fat mass [%] and total trunk fat [%], which has been validated against magnetic resonance imaging for the prediction of abdominal fat percentage (Browning et al., 2010 ), showed a trend toward a positive association with overall changes in systolic BP ( r = +0.32, p = 0.09).
However, mulberry leaf supplementation reduced the average weight ( P < 0.05) of laying hens and showed a trend toward a lower mortality rate than the control group ( P = 0.09).